ROCK1 promotes B cell differentiation and proteostasis under stress through the heme-regulated proteins, BACH2 and HRI
The mechanisms utilized by differentiating B cells to withstand highly damaging conditions generated during severe infections, like the massive hemolysis that accompanies malaria, are poorly understood. Here, we demonstrate that ROCK1 regulates B cell differentiation in hostile environments replete with pathogen-associated molecular patterns (PAMPs) and high levels of heme by controlling 2 key heme-regulated molecules, BACH2 and heme-regulated eIF2α kinase (HRI). ROCK1 phosphorylates BACH2 and protects it from heme-driven degradation. As B cells differentiate, furthermore, ROCK1 restrains their pro-inflammatory potential and helps them handle the heightened stress imparted by the presence of PAMPs and heme by controlling HRI, a key regulator of the integrated stress response and cytosolic proteotoxicity. ROCK1 controls the interplay of HRI with HSP90 and limits the recruitment of HRI and HSP90 to unique p62/SQSTM1 complexes that also contain critical kinases like mTOR complex 1 and TBK1, and proteins involved in RNA metabolism, oxidative damage, and proteostasis like TDP-43. Thus, ROCK1 helps B cells cope with intense pathogen-driven destruction by coordinating the activity of key controllers of B cell differentiation and stress responses. These ROCK1-dependent mechanisms may be widely employed by cells to handle severe environmental stresses, and these findings may be relevant for immune-mediated and age-related neurodegenerative disorders.
Authors
- Young‐Bum Kim (ORCID: https://orcid.org/0000-0001-9471-6330)
- Swati Phalke (ORCID: https://orcid.org/0000-0002-9061-0931)
- Sanjay Gupta (ORCID: https://orcid.org/0000-0003-1714-3895)
- Edd Ricker (ORCID: https://orcid.org/0000-0001-8779-1105)
- Daniel E. Jenkins (ORCID: https://orcid.org/0000-0002-6118-5411)
- Juan Rivera‐Correa (ORCID: https://orcid.org/0000-0003-4822-0005)
- Tania Pannellini (ORCID: https://orcid.org/0000-0002-0224-9921)
- Leandro Cerchietti (ORCID: https://orcid.org/0000-0003-0608-1350)
- Zhuoning Li (ORCID: https://orcid.org/0009-0005-9064-8170)
- Ευγενία Γιαννοπούλου
- Alessandra B. Pernis (ORCID: https://orcid.org/0000-0001-8259-1446)
- Danny Flores-Castro
- Yurii V. Chinenov (ORCID: https://orcid.org/0000-0001-5226-8541)
- Matthew M. Miele (ORCID: https://orcid.org/0000-0001-7495-2133)
- Nahuel Zamponi (ORCID: https://orcid.org/0000-0002-9596-1095)
- Stephen Vulcano (ORCID: https://orcid.org/0009-0009-2001-9650)
Institutions
- Hospital for Special Surgery (US)
- Beth Israel Deaconess Medical Center (US)
- Memorial Sloan Kettering Cancer Center (US)
- Harvard University (US)
- City University of New York (US)
- Cornell University (US)
- Precision for Medicine (United States) (US)
- Weill Cornell Medicine (US)
- New York City College of Technology (US)
Publication Details
- Journal
- JCI Insight
- Published
- 2025-02-04
- DOI
- https://doi.org/10.1172/jci.insight.180507
- Citations
- 1
- Primary Topic
- Diabetes and associated disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.82